Design, synthesis, and evaluation of a novel TRAIL-activated HDAC6 inhibitor for the treatment of pulmonary fibrosis.
作者:
主题词
动物(Animals);组蛋白脱乙酰基酶抑制剂(Histone Deacetylase Inhibitors);人类(Humans);小鼠(Mice);药物设计(Drug Design);肺纤维化(Pulmonary Fibrosis);构效关系(Structure-Activity Relationship);TNF相关凋亡诱导配体(TNF-Related Apoptosis-Inducing Ligand);细胞增殖(Cell Proliferation);分子结构(Molecular Structure);剂量效应关系, 药物(Dose-Response Relationship, Drug);小鼠, 近交C57BL(Mice, Inbred C57BL);成纤维细胞(Fibroblasts);男(雄)性(Male);细胞凋亡(Apoptosis)
DOI
10.1016/j.bmc.2024.117924
PMID
39321740
发布时间
2024-10-15
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文